Hutchmed China Limited Adr stock is traded at $14.85, with a volume of 24,795. It is down -1.53% in the last 24 hours and up +10.00% over the past month. HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
Previous Close:
$15.08
Open:
$14.99
24h Volume:
24,795
Relative Volume:
0.42
Market Cap:
$2.58B
Revenue:
$549.97M
Net Income/Loss:
$458.86M
P/E Ratio:
5.66
EPS:
$2.62
Net Cash Flow:
-$89.06M
1W Performance:
-2.04%
1M Performance:
+10.00%
6M Performance:
+17.21%
1Y Performance:
-2.17%
1-Day Range:
$14.81$15.00
1-Week Range:
$14.81$15.48
52-Week Range:
$9.77$16.33
Hutchmed China Limited Adr Stock (HCM) Company Profile
Market Cap
Revenue
Net Income
Cash Flow
EPS